Candel Therapeutics, Inc.（CADL）内部人交易：高管与董事近期交易
过去 18 个月，共有 10 位内部人为 Candel Therapeutics, Inc.（CADL）报告了 20 笔 Form 4 交易（最近一笔 2026-09-11）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-11 | Tak Paul Peter | Chief Executive Officer | 买入 | 125,000 | $193,750 |
| 2026-09-11 | Tak Paul Peter | Chief Executive Officer | 卖出 | 220,866 | $2.5M |
| 2026-09-11 | Tak Paul Peter | Chief Executive Officer | 卖出 | 59,379 | $620,891 |
| 2026-08-19 | Tyagarajan Seshu | Chief Technology Officer | 卖出 | 7,000 | $84,000 |
| 2026-07-01 | Barone Francesca | Chief Scientific Officer | 卖出 | 23,447 | $235,769 |
| 2026-07-01 | Tyagarajan Seshu | Chief Technology Officer | 卖出 | 7,000 | $70,151 |
| 2026-02-26 | Manning Paul B | 董事 | 买入 | 550,458 | $3.0M |
| 2025-07-30 | Nichols William Garrett | Chief Medical Officer | 买入 | 937 | $1,209 |
| 2025-07-30 | Nichols William Garrett | Chief Medical Officer | 卖出 | 937 | $6,540 |
| 2025-07-02 | Nichols William Garrett | Chief Medical Officer | 买入 | 781 | $1,007 |
| 2025-07-02 | Nichols William Garrett | Chief Medical Officer | 卖出 | 781 | $3,936 |
| 2025-06-26 | Manning Paul B | 董事 | 买入 | 1.1M | $5.0M |
| 2025-06-26 | Barone Francesca | Chief Scientific Officer | 买入 | 4,282 | $19,997 |
| 2025-06-26 | Tak Paul Peter | Chief Executive Officer | 买入 | 42,826 | $199,997 |
| 2025-06-26 | Martell Christopher | 董事 | 买入 | 111,349 | $520,000 |
| 2025-06-26 | Nabel Gary J. | 董事 | 买入 | 5,353 | $24,999 |
| 2025-06-26 | Schoch Charles | Chief Financial Officer | 买入 | 5,353 | $24,999 |
| 2025-06-26 | PAPA JOSEPH C | 董事 | 买入 | 64,239 | $299,996 |
| 2025-06-26 | Loggia Nicoletta | 董事 | 买入 | 2,141 | $9,998 |
| 2025-06-26 | Tyagarajan Seshu | Chief Technology Officer | 买入 | 5,353 | $24,999 |
来源：SEC Form 4 申报文件 · 截至 2026-09-11